Novartis AG
COMBINATION COMPOSITIONS COMPRISING FXR AGONISTS FOR TREATING OR PREVENTING A FIBROTIC, CIRRHOTIC DISEASE OR DISORDER
Last updated:
Abstract:
The invention provides pharmaceutical compositions comprising a farnesoid X receptor (FXR) agonist and another therapeutic agent, in particular for treating or preventing liver diseases or disorders.
Status:
Application
Type:
Utility
Filling date:
3 Oct 2017
Issue date:
1 Aug 2019